花斑癣

Schwartz RA. Superficial fungal infections. Lancet. 2004;364:1173-1182.

• 摘要

Gupta AK, Bluhm R, Summerbell R. Pityriasis versicolor. J Eur Acad Dermatol Venereol. 2002;16:19-33.

• 摘要

Gupta AK, Batra R, Bluhm R, et al. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51:785-798.

• 摘要

Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for superficial mycotic infections of the skin: pityriasis (tinea) versicolor. Guidelines/Outcomes Committee. American Academy of Dermatology. J Am Acad Dermatol. 1996;34:287-289.

• 摘要

1.  Schwartz RA. Superficial fungal infections. Lancet. 2004;364:1173-1182.

• 摘要

2.  James WD, Berger TG, Elston DM. Andrews' diseases of the skin: clinical dermatology. 10th ed. Philadelphia, PA: Elsevier; 2006.

3.  Crespo-Erchiga V, Florencio VD. Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis. 2006;19:139-147.

• 摘要

4.  Aljabre SH, Alzayir AA, Abdulghani M, et al. Pigmentary changes of tinea versicolor in dark-skinned patients. Int J Dermatol. 2001;40:273-275.

• 摘要

5.  Pontasch MJ, Kyanko ME, Brodell RT. Tinea versicolor of the face in black children in a temperate region. Cutis. 1989;43:81-84.

• 摘要

6.  Gupta AK, Bluhm R, Summerbell R. Pityriasis versicolor. J Eur Acad Dermatol Venereol. 2002;16:19-33.

• 摘要

7.  Faergemann J, Fredriksson T. Tinea versicolor with regard to seborrheic dermatitis: an epidemiological investigation. Arch Dermatol. 1979;115:966-968.

• 摘要

8.  Odland GF, Kraning KK. Prevalence, morbidity, and cost of dermatological diseases (editorial). J Invest Dermatol. 1979;73:395-401.

• 全文
• 摘要

9.  Wyre HW Jr, Johnson WT. Neonatal pityriasis versicolor. Arch Dermatol. 1981;117:752-753.

• 摘要

10.  Balestri R, Rech G, Piraccini BM, et al. Pityriasis versicolor during anti-TNF-α monoclonal antibody therapy: therapeutic considerations. Mycoses. 2012;55:444-446.

• 摘要

11.  Morishita N, Sei Y. Microreview of pityriasis versicolor and Malassezia species. Mycopathologia. 2006;162:373-376.

• 摘要

12.  Gupta AK, Batra R, Bluhm R, et al. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51:785-798.

• 摘要

13.  Gupta AK, Kogan N, Batra R. Pityriasis versicolor: a review of pharmacological treatment options. Expert Opin Pharmacother. 2005;6:165-178.

• 摘要

14.  Conklin RJ. Common cutaneous disorders in athletes. Sports Med. 1990;9:100-119.

• 摘要

15.  Nazzaro-Porro M, Passi S. Identification of tyrosinase inhibitors in culture of Pityrosporum. J Invest Dermatol. 1978;71:205-208.

• 摘要

16.  De Luca C, Picardo M, Breathnach A, et al. Lipoperoxidase activity of Pityrosporum: characterisation of by-products and possible role in pityriasis versicolor. Exp Dermatol. 1996;5:49-56.

• 摘要

17.  Karaoui R, Bou-Resli M, Alzaid NS, et al. Tinea versicolor: ultrastructural studies on hypopigmented and hyperpigmented skin. Dermatologica. 1981;162:69-85.

• 摘要

18.  Borgers M, Cauwenbergh G, Van De Ven M, et al. Pityriasis versicolor and Pityrosporum ovale: morphogenetic and ultrastructural considerations. Int J Dermatol. 1987;26:586-589.

• 摘要

19.  Thoma W, Kramer HJ, Mayser P. Pityriasis versicolor alba. J Eur Acad Dermatol Venereol. 2005;19:147-152.

• 摘要

20.  Allen HB, Charles CR, Johnson BL. Hyperpigmented tinea versicolor. Arch Dermatol. 1976;112:1110-1112.

• 摘要

21.  Galdari I, El Komy M, Mousa A, et al. Tinea versicolor: histologic and ultrastructural investigation of pigmentary changes. Int J Dermatol. 1992;31:253-256.

• 摘要

22.  Dotz WI, Henrickson DM, Yu GS, et al. Tinea versicolor: a light and electron microscopic study of hyerpigmented skin. J Am Acad Dermatol. 1985;12:37-44.

• 摘要

23.  Kamalam A, Thambiah AS, Bagavandas M, et al. Mycosis in India: study in Madras. Trans R Soc Trop Med Hyg. 1981;75:92-100.

• 摘要

24.  Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol. 2000;1:75-80.

• 摘要

25.  Hafez M, el-Shamy S. Genetic susceptibility in pityriasis versicolor. Dermatologica. 1985;171:86-88.

• 摘要

26.  He SM, Du WD, Yang S, et al. The genetic epidemiology of tinea versicolor in China. Mycoses. 2008;51:55-62.

• 全文
• 摘要

27.  Stein DH. Superficial fungal infections. Pediatr Clin North Am. 1983;30:545-561.

• 摘要

28.  Borelli D, Jacobs PH, Nall L. Tinea versicolor: epidemiologic, clinical, and therapeutic aspects. J Am Acad Dermatol. 1991;25:300-305.

• 摘要

29.  Lohoue Petmy J, Lando AJ, Kaptue L, et al. Superficial mycoses and HIV infection in Yaounde. J Eur Acad Dermatol Venereol. 2004;18:301-304.

• 摘要

30.  Spence-Shishido A, Carr C, Bonner MY, et al. In vivo Gram staining of tinea versicolor. JAMA Dermatol. 2013;149:991-992.

• 摘要

31.  Yang S, Makredes M, O'Donnell P, et al. A case of Hansen Disease presenting as tinea versicolor. Dermatol Online J. 2013;19:7.

• 全文
• 摘要

32.  El-Gothamy Z, Abdel-Fattah A, Ghaly AF. Tinea versicolor hypopigmentation: histochemical and therapeutic studies. Int J Dermatol. 1975;14:510-515.

• 摘要

33.  Faergemann J. Pityrosporum species as a cause of allergy and infection. Allergy. 1999;54:413-419.

• 全文
• 摘要

34.  Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for superficial mycotic infections of the skin: pityriasis (tinea) versicolor. Guidelines/Outcomes Committee. American Academy of Dermatology. J Am Acad Dermatol. 1996;34:287-289.

• 摘要

35.  Croxtall JD, Plosker GL. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology. Drugs. 2009;69:339-359.

• 摘要

36.  Mills OH Jr, Kligman AM. Letter: Tretinoin in tinea versicolor. Arch Dermatol. 1974;110:638.

• 摘要

37.  Shi TW, Ren XK, Yu HX, et al. Roles of adapalene in the treatment of pityriasis versicolor. Dermatology. 2012;224:184-188.

• 摘要

38.  Wedig JH, Kennedy GL Jr, Jenkins DH, et al. Teratologic evaluation of dermally applied zinc pyrithione on swine. Toxicol Appl Pharmacol. 1976;36:255-259.

• 摘要

39.  Nolen GA, Patrick LF, Dierckman TA. A percutaneous teratology study of zinc pyrithione in rabbits. Toxicol Appl Pharmacol. 1975;31:430-433.

• 摘要

40.  Kokturk A, Kaya TI, Ikizoglu G, et al. Efficacy of three short-term regimens of itraconazole in the treatment of pityriasis versicolor. J Dermatolog Treat. 2002;13:185-187.

• 摘要

41.  Köse O, Bülent Taştan H, Riza Gür A, et al. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor. J Dermatolog Treat. 2002;13:77-79.

• 摘要

42.  Wahab MA, Ali ME, Rahman MH, et al. Single dose (400 mg) versus 7 day (200 mg) daily dose itraconazole in the treatment of tinea versicolor: a randomized clinical trial. Mymensingh Med J. 2010;19:72-76.

• 摘要

43.  Medicines and Healthcare Products Regulatory Agency. Press release: oral ketoconazole-containing medicines should no longer be used for fungal infections. July 2013. http://www.mhra.gov.uk/ (last accessed 30 July 2017).

• 全文

44.  European Medicines Agency. European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole. July 2013. http://www.ema.europa.eu/ema/ (last accessed 30 July 2017).

• 全文

45.  US Food and Drug Administration. FDA drug safety communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems. May 2016. http://www.fda.gov/ (last accessed 30 July 2017).

• 全文

46.  Helou J, Obeid G, Moutran R, et al. Pityriasis versicolor: a case of resistance to treatment. Int J Dermatol. 2014;53:e114-e116.

• 摘要

47.  Faergemann J, Djarv L. Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis. 1982;30:542-545;550.

• 摘要

48.  Rausch LJ, Jacobs PH. Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole. Cutis. 1984;34:470-471.

• 摘要

49.  Faergemann J, Gupta AK, Al Mofadi A, et al. Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor. Arch Dermatol. 2002;138:69-73.

• 全文
• 摘要

50.  Jung EG, Bohnert E. Mechanism of depigmentation on pityriasis versicolor alba. Arch Dermatol Res. 1976;256:333-334.

• 摘要

51.  Rubin AI, Bagheri B, Scher RK. Six novel antimycotics. Am J Clin Dermatol. 2002;3:71-81.

• 摘要

52.  Faergemann J, Todd G, Pather S, et al. A double-blind, randomized, placebo-controlled, dose-finding study of oral pramiconazole in the treatment of pityriasis versicolor. J Am Acad Dermatol. 2009;61:971-976.

• 摘要